NCT03445377View on ClinicalTrials.gov

Comparison of Real-tiMe ContInuous gLucosE moNitoriNg With Self-monitorIng of Blood Glucose in Young AduLts With Type 1 diabeteS

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 16, 2018

Primary Completion Date

June 28, 2020

Study Completion Date

June 28, 2020

Conditions
Diabetes Mellitus, Type 1
Interventions
DEVICE

Real-time continuous glucose monitoring

Subjects randomised to Real-time continuous glucose monitoring will be given a Dexcom G5 or similar, training on its use, and HbA1c measurements taken at the start and end of the study. They will also be given validated questionnaires to complete.

DEVICE

Self-monitoring of blood glucose

Subjects randomised to self monitoring of blood glucose will be given a masked CGM which will be applied for one week, during Week 1, 4 and 8. HbA1c measurements will be taken at the start and end of the study. They will also be given validated questionnaires to complete.

Trial Locations (1)

M13 9WL

Manchester Diabetes Centre, Manchester University NHS Foundation Trust, Manchester

All Listed Sponsors
collaborator

DexCom, Inc.

INDUSTRY

lead

Manchester University NHS Foundation Trust

OTHER_GOV

NCT03445377 - Comparison of Real-tiMe ContInuous gLucosE moNitoriNg With Self-monitorIng of Blood Glucose in Young AduLts With Type 1 diabeteS | Biotech Hunter | Biotech Hunter